Exact Sciences Corp (EXAS)
62.10
+1.56
(+2.58%)
USD |
NASDAQ |
May 03, 16:00
62.10
0.00 (0.00%)
After-Hours: 20:00
Exact Sciences Enterprise Value: 12.58B for May 2, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 02, 2024 | 12.58B |
| May 01, 2024 | 12.48B |
| April 30, 2024 | 12.36B |
| April 29, 2024 | 12.26B |
| April 26, 2024 | 12.27B |
| April 25, 2024 | 12.26B |
| April 24, 2024 | 13.07B |
| April 23, 2024 | 13.12B |
| April 22, 2024 | 12.92B |
| April 19, 2024 | 12.65B |
| April 18, 2024 | 13.11B |
| April 17, 2024 | 13.06B |
| April 16, 2024 | 13.18B |
| April 15, 2024 | 13.45B |
| April 12, 2024 | 14.54B |
| April 11, 2024 | 14.83B |
| April 10, 2024 | 14.95B |
| April 09, 2024 | 15.07B |
| April 08, 2024 | 14.54B |
| April 05, 2024 | 14.34B |
| April 04, 2024 | 14.32B |
| April 03, 2024 | 14.81B |
| April 02, 2024 | 14.97B |
| April 01, 2024 | 14.37B |
| March 28, 2024 | 14.12B |
| Date | Value |
|---|---|
| March 27, 2024 | 13.73B |
| March 26, 2024 | 13.43B |
| March 25, 2024 | 13.16B |
| March 22, 2024 | 12.86B |
| March 21, 2024 | 12.84B |
| March 20, 2024 | 12.96B |
| March 19, 2024 | 12.82B |
| March 18, 2024 | 12.27B |
| March 15, 2024 | 12.06B |
| March 14, 2024 | 12.21B |
| March 13, 2024 | 12.67B |
| March 12, 2024 | 12.61B |
| March 11, 2024 | 12.61B |
| March 08, 2024 | 12.49B |
| March 07, 2024 | 12.74B |
| March 06, 2024 | 11.80B |
| March 05, 2024 | 12.21B |
| March 04, 2024 | 12.33B |
| March 01, 2024 | 12.38B |
| February 29, 2024 | 12.03B |
| February 28, 2024 | 11.81B |
| February 27, 2024 | 11.92B |
| February 26, 2024 | 12.03B |
| February 23, 2024 | 12.03B |
| February 22, 2024 | 12.39B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
6.113B
Minimum
Mar 18 2020
26.52B
Maximum
Feb 12 2021
14.55B
Average
13.73B
Median
Enterprise Value Benchmarks
| Illumina Inc | 20.14B |
| Natera Inc | 10.94B |
| Guardant Health Inc | 2.238B |
| Quest Diagnostics Inc | 19.50B |
| Castle Biosciences Inc | 388.65M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -49.77M |
| Revenue (Quarterly) | 646.88M |
| Total Expenses (Quarterly) | 714.68M |
| EPS Diluted (Quarterly) | -0.27 |
| Gross Profit Margin (Quarterly) | 73.44% |
| Profit Margin (Quarterly) | -7.69% |
| Earnings Yield | -1.83% |
| Normalized Earnings Yield | -2.172 |